BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 2483177)

  • 1. [Clinicopathological study of juvenile hepatocellular carcinoma].
    Furusawa A; Unoura M; Notsumata K; Morioka T; Hayakawa K; Matsushita E; Kobayashi K; Hattori N; Makino H; Fukuoka K
    Nihon Shokakibyo Gakkai Zasshi; 1989 Dec; 86(12):2765-72. PubMed ID: 2483177
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Childhood hepatocellular carcinoma develops exclusively in hepatitis B surface antigen carriers in three decades in Taiwan. Report of 51 cases strongly associated with rapid development of liver cirrhosis.
    Hsu HC; Wu MZ; Chang MH; Su IJ; Chen DS
    J Hepatol; 1987 Dec; 5(3):260-7. PubMed ID: 2828461
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [A clinicopathological study of 108 consecutive primary hepatic malignancies in the University of Occupational and Environmental Health].
    Haratake J; Horie A; Taoka Y; Okuno F; Takeda S; Sato H
    Gan No Rinsho; 1987 Oct; 33(13):1689-93. PubMed ID: 2447304
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evolution of expression of hepatitis B surface and core antigens (HBsAg, HBcAg) in resected primary and recurrent hepatocellular carcinoma in HBsAg carriers in Taiwan. Correlation with local host immune response.
    Hsu HC; Wu TT; Wu MZ; Wu CY; Chiou TJ; Sheu JC; Lee CS; Chen DS
    Cancer; 1988 Sep; 62(5):915-21. PubMed ID: 2842026
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Hepatitis and hepatocellular carcinoma].
    Ichida F
    Gan No Rinsho; 1983 May; 29(6):469-73. PubMed ID: 6308305
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatocellular carcinoma. A study of 50 autopsy cases with detection of hepatitis B surface antigen in fixed tissues.
    Perez-Barrios A; Colina-Ruizdelgado F; Gallego I; Martinez-Tello FJ
    Pathol Res Pract; 1983 Mar; 176(2-4):131-44. PubMed ID: 6190153
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinicopathological features of hepatocellular carcinoma--comparison of hepatitis B seropositive and seronegative patients.
    Okuda H; Obata H; Motoike Y; Hisamitsu T
    Hepatogastroenterology; 1984 Apr; 31(2):64-8. PubMed ID: 6202615
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Primary hepatocellular carcinoma and hepatitis B infection during childhood.
    Wu TC; Tong MJ; Hwang B; Lee SD; Hu MM
    Hepatology; 1987; 7(1):46-8. PubMed ID: 2433204
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HBsAg-negative hepatitis B virus infections in hepatitis C virus-associated hepatocellular carcinoma.
    Momosaki S; Nakashima Y; Kojiro M; Tabor E
    J Viral Hepat; 2005 May; 12(3):325-9. PubMed ID: 15850475
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatitis B antigen in the liver in hepatocellular carcinoma in Shikoku, Japan.
    Akagi G; Furuya K; Otsuka H
    Cancer; 1982 Feb; 49(4):678-82. PubMed ID: 6275977
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Small and asymptomatic hepatocellular carcinoma detected by alpha-fetoprotein screening in black hepatitis B carriers. A report of 2 cases.
    Dusheiko GM; Conradie JC; Bowyer SM; Simjee A; Epstein B; Levien LJ; Beale P; Kew MC
    S Afr Med J; 1986 Jan; 69(2):129-32. PubMed ID: 2417341
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum alphafetoprotein in hepatocellular carcinoma.
    Chen DS; Sung JL
    Cancer; 1977 Aug; 40(2):779-83. PubMed ID: 70268
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Paraneoplastic syndrome frequency and prognostic effect in hepatocellular carcinoma patients.
    Ülger Y; Delik A
    Eur J Gastroenterol Hepatol; 2022 Jul; 34(7):769-773. PubMed ID: 34974464
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatocellular carcinoma in young, mentally retarded HBsAg carriers without cirrhosis.
    Lohiya G; Pirkle H; Hoefs J; Lohiya S; Ngo VT
    Hepatology; 1985; 5(5):824-6. PubMed ID: 2993146
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatitis-B surface antigen and hepatocellular carcinoma in Taiwan. With special reference to types and localization of HBsAg in the tumor cells.
    Hsu HC; Lin WS; Tsai MJ
    Cancer; 1983 Nov; 52(10):1825-32. PubMed ID: 6313175
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical features and etiology of hepatocellular carcinoma arising in patients with membranous obstruction of the inferior vena cava: in reference to hepatitis viral infection.
    Matsui S; Ichida T; Watanabe M; Sugitani S; Suda T; Takahashi T; Asakura H
    J Gastroenterol Hepatol; 2000 Oct; 15(10):1205-11. PubMed ID: 11106103
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A prospective study on the development of hepatocellular carcinoma from liver cirrhosis with persistent hepatitis B virus infection.
    Obata H; Hayashi N; Motoike Y; Hisamitsu T; Okuda H; Kobayashi S; Nishioka K
    Int J Cancer; 1980 Jun; 25(6):741-7. PubMed ID: 14768703
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatocellular carcinoma. A clinical and pathologic analysis of 57 hepatectomy cases.
    Kishi K; Shikata T; Hirohashi S; Hasegawa H; Yamazaki S; Makuuchi M
    Cancer; 1983 Feb; 51(3):542-8. PubMed ID: 6185205
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Soluble human leukocyte antigen-G expression in hepatitis B virus infection and hepatocellular carcinoma.
    Park Y; Park Y; Lim HS; Kim YS; Hong DJ; Kim HS
    Tissue Antigens; 2012 Feb; 79(2):97-103. PubMed ID: 22136460
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alpha-fetoprotein as a tumor marker in hepatocellular carcinoma: investigations in south Indian subjects with hepatotropic virus and aflatoxin etiologies.
    Murugavel KG; Mathews S; Jayanthi V; Shankar EM; Hari R; Surendran R; Vengatesan A; Raghuram K; Rajasambandam P; Murali A; Srinivas U; Palaniswamy KR; Pugazhendhi T; Thyagarajan SP
    Int J Infect Dis; 2008 Nov; 12(6):e71-6. PubMed ID: 18658001
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.